Weight-loss drug boom raises questions about the PHARMACEUTICAL INDustry

publicat 2026-05-06 00:00:08 (Bursa)
The spectacular increase in demand for obesity and diabetes drugs, especially those in the GLP-1 class, is starting to raise concerns about the emergence of a possible 'bubble and #8221; in the PHARMACEUTICAL INDustry, according to a report by Deloitte and cited by CNBC. ...continuare.

Johnson and Johnson accelerates drug development with artificial intelligence

publicat 2026-04-29 00:00:13 (Bursa)
American pharmaceutical giant Johnson and Johnson is increasingly relying on artificial intelligence to significantly reduce the time required to research and develop new treatments, at a time when the PHARMACEUTICAL INDustry is looking for solutions to shorten extremely expensive and time-consuming processes. According to the company and #39;s IT director, Jim Swanson, quoted by Reuters, AI has already managed to halve the time required to identify... ...continuare.
EMAG


© Copyright 2000-2026 iStorm. Toate drepturile rezervate.